Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2014; 4(9): 073-076


An approach for validated RP-HPLC method for the analysis of paclitaxel in rat plasma

Nandhakumar Sathyamoorthy, Vijayalakshmi Rajendran, Naveena V.S.H, Magharla Dasaratha Dhanaraju.




Abstract

This report describes analysis of paclitaxel, which is an antineoplastic drug used in the treatment of kaposi's sarcoma and cancer of the lung by isocratic high performace liquid chromatography with UV detection in pure and rat plasma. The analysis was carried out using phenomenex C18 (250 x 4.6 mm, 5 µm particle size) column with a mobile phase consisting of acetonitrile and phosphate buffer (pH 5) in the ratio of 80:20%, v/v. Paclitaxel was eluted at the retention time of 5.3 min when operated at the flow rate of 1 ml/min and monitored by UV at 227 nm. Paclitaxel was extracted from rat plasma by simple LLE method using non- toxic ethyl acetate as extraction solvent. The linearity was accessed in the concentration range of 100-600 µg/mL with correlation coefficient of 0.9999 and percentage recovery of 99.86. The liquid chromatography method was extensively validated for linearity, accuracy, precision, LOD, LOQ and robustness. All these analytical validation parameters were observed to be satisfactory, which indicates the usefulness of method for determination of paclitaxel in pure form and rat plasma. No interfering peaks were observed during the analysis.

Key words: Paclitaxel; validation; RP-HPLC; acetonitrile; Buffer (pH 5)






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.